Understanding <scp>anti‐TNF</scp> treatment failure: does serum triiodothyronine‐to‐thyroxine ( <scp>T3</scp> / <scp>T4</scp> ) ratio predict therapeutic outcome to <scp>anti‐TNF</scp> therapies in biologic‐naïve patients with active luminal Crohn's disease?-Reference-Cited by-同舟云学术

Understanding anti‐TNF treatment failure: does serum triiodothyronine‐to‐thyroxine ( T3 / T4 ) ratio predict therapeutic outcome to anti‐TNF therapies in biologic‐naïve patients with active luminal Crohn's disease?

Published:2022-06-29 Issue:5 Volume:56 Page:783-793
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Lin Simeng¹²^ORCID,Chanchlani Neil¹²^ORCID,Carbery Isabel³⁴,Janjua Malik¹²,Nice Rachel⁵,McDonald Timothy J.⁵^ORCID,Bewshea Claire²^ORCID,Kennedy Nicholas A.¹²^ORCID,Ahmad Tariq¹²^ORCID,Selinger Christian P.³⁴^ORCID,Goodhand James R.¹²^ORCID,

Affiliation:

1. Gastroenterology Royal Devon and Exeter NHS Foundation Trust Exeter UK

2. Exeter Inflammatory Bowel Disease and Pharmacogenetics Research Group University of Exeter Exeter UK

3. Leeds Gastroenterology Institute, Leeds Teaching Hospitals NHS Trust Leeds UK

4. The Leeds Institute of Research at St James' University of Leeds Leeds UK

5. Biochemistry, Exeter Clinical Laboratory International Royal Devon and Exeter NHS Foundation Trust Exeter UK

Funder

AbbVie

Celltrion Healthcare

Center for Outcomes Research and Evaluation, Yale School of Medicine

Crohn's and Colitis UK

Merck Sharp and Dohme

Pfizer

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17089

Reference31 articles.

1. Incidence and prevalence of inflammatory bowel disease in Devon, UK;Hamilton B;Frontline Gastroenterol,2020

2. IBD prevalence in Lothian, Scotland, derived by capture–recapture methodology

3. Thyroid function in critically ill patients

4. An update on non-thyroidal illness syndrome

5. Sick Euthyroid Syndrome on Presentation of Patients With COVID-19: A Potential Marker for Disease Severity

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study;The Lancet Gastroenterology & Hepatology;2024-06

2. Diagnosis and management of inflammatory bowel disease;Journal of Evidence-Based Medicine;2024-06

3. Challenges in IBD Research 2024: Precision Medicine;Inflammatory Bowel Diseases;2024-05-01

4. Precision medicine in inflammatory bowel disease;Precision Clinical Medicine;2023-10-25

5. Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn’s Disease;Crohn's & Colitis 360;2023-05-15